Northeast Financial Consultants’s DexCom DXCM Stock Holding History

Northeast Financial Consultants’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,648	Closed	-$421K	–	343
2022 Q2	$421K	Hold	5,648	–	–	0.03%	212
2022 Q1	$722K	Hold	5,648	–	–	0.04%	185
2021 Q4	$758K	Hold	5,648	–	–	0.05%	182
2021 Q3	$772K	Hold	5,648	–	–	0.05%	180
2021 Q2	$603K	Hold	5,648	–	–	0.04%	202
2021 Q1	$507K	Buy	5,648 +492	+10%	+$46.2K	0.04%	209
2020 Q4	$477K	Buy	5,156 +1,992	+63%	+$178K	0.04%	202
2020 Q3	$326K	Hold	3,164	–	–	0.03%	222
2020 Q2	$321K	Buy	+3,164	New	+$283K	0.03%	212

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northeast Financial Consultants's DXCM Position: Q3 2022 in Review

Northeast Financial Consultants sold out of DexCom (DXCM) in Q3 2022, closing a stake of 5,648 shares — an estimated $421K sold.

Northeast Financial Consultants first reported a position in DXCM in Q2 2020 and held it in 9 quarters. The position peaked at $772K in Q3 2021. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

Northeast Financial Consultants reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
Northeast Financial Consultants sold 5,648 DexCom shares in Q3 2022, an estimated $421K.
Northeast Financial Consultants first reported a position in DexCom in Q2 2020 and held it in 9 quarters.
Northeast Financial Consultants's DexCom position peaked at $772K in Q3 2021.
794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Northeast Financial Consultants's 13F filing for Q3 2022, filed 15 Nov 2022.